Santee, CA, United States of America

Brons M Larson

USPTO Granted Patents = 1 

Average Co-Inventor Count = 17.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Brons M Larson: Innovator in Bioagent Detection

Introduction

Brons M Larson is a notable inventor based in Santee, CA (US). He has made significant contributions to the field of bioagent detection through his innovative patent. His work focuses on methods and apparatus for genetic evaluation, which has important implications for various industries.

Latest Patents

Brons M Larson holds a patent for "Methods and apparatus for genetic evaluation." This invention allows for rapid and definitive bioagent detection and identification without the need for nucleic acid sequencing. The technology enables the analysis of various bioagents and samples, including air, fluid, and body samples. This information is valuable for industrial, medical, and environmental purposes. The process involves collecting nucleic acid samples of unknown or suspected bioagents, selecting optimal primer pairs, and amplifying the nucleic acid. Expected mass spectra signal models are generated, and the actual mass spectra of the amplicons are obtained. A joint maximum likelihood analysis is used to determine the expected mass spectra that most closely correlates with the actual mass spectra. Ultimately, this leads to the identification of the most likely candidate bioagents.

Career Highlights

Brons M Larson is associated with Ibis Biosciences, Inc., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of bioagent detection.

Collaborations

Throughout his career, Brons has collaborated with notable individuals such as David J Ecker and Richard Holmes Griffey. These collaborations have further enhanced the impact of his work in the scientific community.

Conclusion

Brons M Larson's innovative contributions to bioagent detection demonstrate the importance of advancements in genetic evaluation methods. His patent reflects a significant step forward in the ability to identify and analyze bioagents effectively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…